Strategic Wealth Partners Ltd. Acquires Shares of 40,683 Establishment Labs Holdings Inc. (NASDAQ:ESTA)

Strategic Wealth Partners Ltd. bought a new stake in Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 40,683 shares of the company's stock, valued at approximately $1,874,000. Strategic Wealth Partners Ltd. owned 0.15% of Establishment Labs as of its most recent SEC filing.

A number of other large investors also recently added to or reduced their stakes in ESTA. Toronto Dominion Bank acquired a new stake in shares of Establishment Labs in the fourth quarter valued at $24,879,000. Brown Advisory Inc. boosted its holdings in Establishment Labs by 23.1% during the 4th quarter. Brown Advisory Inc. now owns 2,338,369 shares of the company's stock valued at $107,729,000 after acquiring an additional 438,057 shares during the period. Capital Research Global Investors grew its position in Establishment Labs by 29.3% in the 4th quarter. Capital Research Global Investors now owns 1,911,525 shares of the company's stock valued at $88,064,000 after acquiring an additional 433,484 shares in the last quarter. Voya Investment Management LLC grew its position in Establishment Labs by 7,249.5% in the 4th quarter. Voya Investment Management LLC now owns 408,262 shares of the company's stock valued at $18,809,000 after acquiring an additional 402,707 shares in the last quarter. Finally, Millennium Management LLC increased its stake in Establishment Labs by 96.9% during the fourth quarter. Millennium Management LLC now owns 711,691 shares of the company's stock worth $32,788,000 after purchasing an additional 350,213 shares during the period. 72.91% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

ESTA has been the subject of several recent research reports. Stephens reissued an "overweight" rating and issued a $52.00 price objective on shares of Establishment Labs in a research note on Thursday, March 6th. Wall Street Zen cut shares of Establishment Labs from a "hold" rating to a "sell" rating in a research report on Thursday. Needham & Company LLC raised Establishment Labs from a "hold" rating to a "buy" rating and set a $48.00 price objective on the stock in a research report on Wednesday, May 14th. Finally, BTIG Research initiated coverage on Establishment Labs in a research note on Friday, May 16th. They issued a "buy" rating and a $62.00 price objective on the stock. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $55.33.

Establishment Labs Stock Down 2.2%

Shares of NASDAQ:ESTA traded down $0.83 during trading hours on Friday, reaching $36.03. The stock had a trading volume of 164,692 shares, compared to its average volume of 470,366. Establishment Labs Holdings Inc. has a 1 year low of $26.56 and a 1 year high of $58.00. The firm's 50 day moving average is $34.37 and its 200-day moving average is $38.03. The stock has a market capitalization of $1.04 billion, a price-to-earnings ratio of -13.96 and a beta of 0.73. The company has a debt-to-equity ratio of 5.94, a quick ratio of 2.29 and a current ratio of 3.62.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last posted its earnings results on Wednesday, May 7th. The company reported ($0.70) EPS for the quarter, beating the consensus estimate of ($0.83) by $0.13. The firm had revenue of $41.38 million for the quarter, compared to analyst estimates of $41.15 million. Establishment Labs had a negative return on equity of 184.55% and a negative net margin of 46.13%. Establishment Labs's revenue for the quarter was up 11.3% compared to the same quarter last year. During the same quarter in the prior year, the company posted ($0.58) earnings per share. Research analysts predict that Establishment Labs Holdings Inc. will post -2.41 earnings per share for the current fiscal year.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.